Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1130320160590050231
Korean Journal of Pediatrics
2016 Volume.59 No. 5 p.231 ~ p.238
Lipopolysaccharide-binding protein plasma levels as a biomarker of obesity-related insulin resistance in adolescents
Kim Ki-Eun

Cho Young-Sun
Baek Kyung-Suk
Lan Li
Baek Kwang-Hyun
Kim Jung-Hyun
Kim Ho-Seong
Sheen Youn-Ho
Abstract
Purpose: Lipopolysaccharide-binding protein (LBP) is a 65-kDa acute phase protein, derived from the liver, which is present in high concentrations in plasma. Data regarding the association between circulating plasma LBP levels and obesity-related biomarkers in the pediatric population are scarce. We aimed to determine whether there was a difference in plasma LBP levels between overweight/ obese and normal-weight adolescents and to assess the correlation of circulating LBP levels with anthropometric measures and obesity-related biomarkers, including insulin resistance, liver enzyme levels, and lipid profiles.

Methods: The study included 87 adolescents aged 12?13 years; 44 were overweight/obese and 43 were of normal-weight. We assessed anthropometric and laboratory measures, including body mass index (BMI), blood pressure, insulin sensitivity, liver enzyme levels, and lipid profiles. Plasma LBP levels were measured using an enzyme-linked immunosorbent assay.

Results: The mean age of the participants was 12.9¡¾0.3 years. Circulating plasma LBP levels were significantly increased in overweight/obese participants compared with those in normal-weight participants (P<0.0001). LBP levels were significantly and positively associated with BMI; systolic and diastolic blood pressure; total cholesterol, low density lipoprotein-cholesterol, triglyceride, aspartate aminotransferase, and alanine aminotransferase levels; and insulin resistance as indicated by the homeostasis model assessment of insulin resistance (HOMA-IR) (all P<0.05). In multivariate linear regression analysis, BMI and HOMA-IR were independently and positively associated with plasma LBP levels.

Conclusion: LBP is an inflammatory biomarker associated with BMI and obesity-related insulin resistance in adolescents. The positive correlation between these parameters suggests a potentially relevant pathophysiological mechanism linking LBP to obesity-related insulin resistance in adolescents.
KEYWORD
Lipopolysaccharide-binding protein , Body mass index , Insulin resistance , Adolescent , Obesity
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø